ADHD meds may curb binge eating in kids, tiny study suggests

NCT ID NCT05592119

First seen Jan 21, 2026 · Last updated Jun 19, 2026 · Updated 25 times

Summary

This study looked at whether stimulant medication can reduce loss of control eating in children aged 8 to 13 with ADHD. Ten kids were followed for 3 months after starting stimulants. Researchers measured changes in eating episodes and behaviors to see if treating ADHD symptoms might also prevent later eating disorders.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT HYPERACTIVITY DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Abbie J Lane Memorial Building - QEII

    Halifax, Nova Scotia, B3H 2E2, Canada

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

stimulant medication

What this could lead to

If it works, this could point toward a way to prevent full-blown eating disorders in youth with ADHD by treating loss of control eating early.

What could go wrong

This is a very small observational study with only 10 participants and no control group. Results may not apply to all children, and stimulants have side effects like appetite loss and sleep problems.

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder binge eating disorder Feeding and Eating Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.